Song Jiang1, Yongmei Li1. 1. Department of Radiology, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, China.
Abstract
AIM: This paper aims to explore the practical value of CT signs combined with magnetic resonance imaging with diffusion-weighted imaging (MRI-DWI) and magnetic resonance cholangiopancreatography (MRCP) in the differential diagnosis of pancreatic carcinoma and mass-forming pancreatitis. METHODS: We carried out a retrospective analysis of the imaging data of 61 patients with pancreatic mass lesions who were diagnosed based on postoperative pathology in our hospital from May 2013 to May 2020 and analyzed the image diagnostic value of the combination of 128-slice CT and 1.5T MRI-DWI. RESULTS: There were no significant differences in the pancreatic duct dilatation, the bile duct dilatation, or the peripancreatic and retroperitoneal lymph node enlargement between the patients with pancreatic carcinoma and the patients with mass-forming pancreatitis (P > 0.05). Both the incidences of lobulation signs and peripancreatic vascular invasion in the patients with pancreatic carcinoma were higher than they were in the patients with mass-forming pancreatitis, and the mass calcification, pseudocyst, and pancreatic duct stone rates, the net enhanced CT values in the arterial and pancreatic parenchyma phases, and the ADC values in pancreatic carcinoma patients were lower than they were in the patients with mass-forming pancreatitis (P < 0.05). The pancreatic duct stone and right prerenal fascial thickening rates in the patients with pancreatic carcinoma were lower than they were in the patients with mass-forming pancreatitis (P < 0.05). CONCLUSION: CT signs combined with the MRI-DWI technique and MRCP can improve clinical pancreatic cancer diagnostic sensitivity. AJTR
AIM: This paper aims to explore the practical value of CT signs combined with magnetic resonance imaging with diffusion-weighted imaging (MRI-DWI) and magnetic resonance cholangiopancreatography (MRCP) in the differential diagnosis of pancreatic carcinoma and mass-forming pancreatitis. METHODS: We carried out a retrospective analysis of the imaging data of 61 patients with pancreatic mass lesions who were diagnosed based on postoperative pathology in our hospital from May 2013 to May 2020 and analyzed the image diagnostic value of the combination of 128-slice CT and 1.5T MRI-DWI. RESULTS: There were no significant differences in the pancreatic duct dilatation, the bile duct dilatation, or the peripancreatic and retroperitoneal lymph node enlargement between the patients with pancreatic carcinoma and the patients with mass-forming pancreatitis (P > 0.05). Both the incidences of lobulation signs and peripancreatic vascular invasion in the patients with pancreatic carcinoma were higher than they were in the patients with mass-forming pancreatitis, and the mass calcification, pseudocyst, and pancreatic duct stone rates, the net enhanced CT values in the arterial and pancreatic parenchyma phases, and the ADC values in pancreatic carcinomapatients were lower than they were in the patients with mass-forming pancreatitis (P < 0.05). The pancreatic duct stone and right prerenal fascial thickening rates in the patients with pancreatic carcinoma were lower than they were in the patients with mass-forming pancreatitis (P < 0.05). CONCLUSION: CT signs combined with the MRI-DWI technique and MRCP can improve clinical pancreatic cancer diagnostic sensitivity. AJTR
Authors: James R Hocker; Russell G Postier; Min Li; Megan R Lerner; Stan A Lightfoot; Marvin D Peyton; Subrato J Deb; Candace M Baker; Travis L Williams; Rushie Jane Hanas; Donald E Stowell; Theresa J Lander; Daniel J Brackett; Jay S Hanas Journal: Cancer Lett Date: 2015-01-28 Impact factor: 8.679
Authors: Petr Dite; Ivo Novotny; Jana Dvorackova; Bohuslav Kianicka; Martin Blaho; Pavel Svoboda; Magdalena Uvirova; Tomas Rohan; Hana Maskova; Lumir Kunovsky Journal: Dig Dis Date: 2019-05-10 Impact factor: 2.404
Authors: Julia Mayerle; Holger Kalthoff; Regina Reszka; Beate Kamlage; Erik Peter; Bodo Schniewind; Sandra González Maldonado; Christian Pilarsky; Claus-Dieter Heidecke; Philipp Schatz; Marius Distler; Jonas A Scheiber; Ujjwal M Mahajan; F Ulrich Weiss; Robert Grützmann; Markus M Lerch Journal: Gut Date: 2017-01-20 Impact factor: 23.059
Authors: Entesar Dalah; Beth Erickson; Kiyoko Oshima; Diane Schott; William A Hall; Eric Paulson; An Tai; Paul Knechtges; X Allen Li Journal: Transl Oncol Date: 2018-02-20 Impact factor: 4.243